[Skip to Navigation]
Sign In
December 2018

Omitted Dates of Ethical Approval and Timing of Patient Recruitment

JAMA Pediatr. 2018;172(12):1205. doi:10.1001/jamapediatrics.2018.3632

In the Original Investigation titled “Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial,”1 published online June 18, 2018, and in the August 2018 issue of JAMA Pediatrics, specific dates of approval from the institutional review board of Nilratan Sircar Medical College and Hospital (December 2013) and the drug regulatory authority of India (April 2015) and the related explanation for the timing of patient recruitment in the trial were not included in the Methods section. The article has been corrected online.

Basu  B, Sander  A, Roy  B,  et al.  Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial.  JAMA Pediatr. 2018;172(8):757-764. doi:10.1001/jamapediatrics.2018.1323Google ScholarCrossref